Sinai Post Acute Nursing And Rehab Center Medicare and Medicaid Location: 65 Jay Street, Newark, New Jersey 07103 Ratings: Phone: (973) 483-6800 |
Broadway House For Continuing Medicare and Medicaid Location: 298 Broadway, Newark, New Jersey 07104 Ratings: Phone: (973) 268-9797 |
Forest Hill Healthcare Center Medicare and Medicaid Location: 497 Mt Prospect Ave, Newark, New Jersey 07104 Ratings: Phone: (973) 482-5000 |
New Community Extended Care Facility Medicare and Medicaid Location: 266 S Orange Ave, Newark, New Jersey 07103 Ratings: Phone: (973) 624-2020 |
New Vista Nursing & Rehabilitation Ctr Medicare and Medicaid Location: 300 Broadway, Newark, New Jersey 07104 Ratings: Phone: (973) 484-4222 |
News Archive
Although there have been discussions about chronic obstructive pulmonary disease (COPD), a condition impacting 24 million Americans, and depression, there has been little research showing the impact depression has on patients with COPD. Two studies published in the April issue of the journal CHEST found one in four patients with COPD suffer from depressive symptoms, and if not treated, those symptoms can have a negative effect on their overall health and treatment effectiveness.
Urologists at Henry Ford Hospital have developed a new technique that could make minimally invasive robotic partial nephrectomy procedures the norm, rather than the exception for kidney cancer patients. The technique spares the kidney, eliminates long hospital stays and provides better outcomes by giving the surgeon more time to perform the procedure.
The chance of dying from cancer before the age of 84 is becoming much smaller for most types of cancer and should continue falling over the next 20 years according to a new study from Cancer Research UK.
G8 development ministers "agreed to a set of guiding principles [for Canada's G8 maternal and child health initiative] that leaves flexibility for countries to 'build their basket of initiatives,'" Bev Oda, the Canadian minister for international cooperation, said at a closing news conference on Wednesday, the Toronto Star reports.
Cancer diagnostics company Biomoda, Inc. is working with the Saccomanno Research Institute to advance Biomoda's patented system for measuring the photon emission rate of CyPath-stained cells to detect early-stage lung cancer.
› Verified 9 days ago